Preprint Review Version 1 This version is not peer-reviewed

Basic-Clinical Analysis of Parathyroid Cancer

Version 1 : Received: 5 August 2024 / Approved: 6 August 2024 / Online: 6 August 2024 (10:25:55 CEST)

How to cite: Fuenzalida, L.; Indo, S.; Contreras, H.; Rappoport, D.; Cabané, P. Basic-Clinical Analysis of Parathyroid Cancer. Preprints 2024, 2024080415. https://doi.org/10.20944/preprints202408.0415.v1 Fuenzalida, L.; Indo, S.; Contreras, H.; Rappoport, D.; Cabané, P. Basic-Clinical Analysis of Parathyroid Cancer. Preprints 2024, 2024080415. https://doi.org/10.20944/preprints202408.0415.v1

Abstract

Parathyroid cancer (PC) presents clinically as a case of hyperparathyroidism associated with local compression symptoms. The definitive diagnosis of PC is complex as it requires unequivocal criteria of invasion in postoperative biopsy. Given the difficulty in confirming the diagnosis of PC, attempts have been made to address this problem through the search for biomarkers, mainly using immunohistochemistry. Within this theme, the phenomenon of epithelial-mesenchymal transition and cancer stem cells markers have been scarcely studied; and could eventually help discriminate between a diagnosis of parathyroid adenoma or carcinoma. This review presents a clinical approach to the disease; as well as providing a state of the art analysis of basic biomarkers in diagnosis and future projections in this field.

Keywords

parathyroid cancer; primary hyperparathyroidism; biomarkers; epithelial-mesenchymal transition (EMT)

Subject

Biology and Life Sciences, Other

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.